<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PubTator</source><date>2020-12-04</date><key>BioC.key</key>
<document><id>27677546</id><passage><infon key="type">title</infon><offset>0</offset><text>Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation.</text></passage><passage><infon key="type">abstract</infon><offset>138</offset><text>Monocyte/macrophages of patients with mild cognitive impairment (MCI) and Alzheimer disease (AD) are defective in phagocytosis and degradation amyloid β1-42 (Aβ1-42), but are improved by ω-3 fatty acids (ω-3s). The hypothesis of this study was that active Aβ1-42 phagocytosis by macrophages prevents brain amyloidosis and thus maintains cognition. We studied the effects of self-supplementation with a drink with ω-3s, antioxidants, and resveratrol on Mini-Mental State Examination (MMSE) scores, macrophage M1M2 phenotype [the ratio of inflammatory cluster of differentiation (CD)54+CD80 and proresolution markers CD163+CD206], and Aβ1-42 phagocytosis in patients initially diagnosed as having MCI or subjective cognitive impairment (SCI). At baseline, the median MMSE score in patients in both the apolipoprotein E (ApoE) ε3/ε3 and ApoE ε3/ε4 groups was 26.0 and macrophage Aβ1-42 phagocytosis was defective. The MMSE rate of change increased in the ApoE ε3/ε3 group a median 2.2 points per year (P = 0.015 compared to 0) but did not change in the ApoE ε3/ε4 group (P = 0.014 between groups). In the ApoE ε3/ε3 group, all patients remained cognitively stable or improved; in the ApoE ε3/ε4 group, 1 recovered from dementia, but 3 lapsed into dementia. The macrophage phenotype polarized in patients bearing ApoE ε3/ε3 to an intermediate (green zone) M1-M2 type at the rate of 0.226 U/yr, whereas in patients bearing ApoE ε3/ε4, polarization was negative (P = 0.08 between groups). The baseline M1M2 type in the extreme M1 (red zone) or M2 (white zone) was unfavorable for cognitive outcome. Aβ1-42 phagocytosis increased in both ApoE groups (P = 0.03 in each groups). In vitro, the lipidic mediator resolvin D1 (RvD1) down regulated the M1 type in patients with ApoE ε3/ε3 but in some patients with ε3/ε4, paradoxically up-regulated the M1 type. Antioxidant/ω-3/resveratrol supplementation was associated with favorable immune and cognitive responses in ApoE ε3/ε3 and individual patients bearing ApoE ε3/ε4, and brings into personalized clinical practice the immune benefits expected from ω-3 mediators called resolvins. The validity of this study is limited by its small size and uncontrolled design.-Famenini, S., Rigali, E. A., Olivera-Perez, H. M., Dang, J., Chang, M T., Halder, R., Rao, R. V., Pellegrini, M., Porter, V., Bredesen, D., Fiala, M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation.</text><annotation id="0"><infon key="NCBI Gene identifier">351</infon><infon key="type">Gene</infon><location offset="281" length="13"/><text>amyloid β1-42</text></annotation><annotation id="1"><infon key="NCBI Gene identifier">351</infon><infon key="type">Gene</infon><location offset="296" length="6"/><text>Aβ1-42</text></annotation><annotation id="2"><infon key="NCBI Gene identifier">351</infon><infon key="type">Gene</infon><location offset="394" length="6"/><text>Aβ1-42</text></annotation><annotation id="3"><infon key="NCBI Gene identifier">3383</infon><infon key="type">Gene</infon><location offset="715" length="6"/><text>(CD)54</text></annotation><annotation id="4"><infon key="NCBI Gene identifier">941</infon><infon key="type">Gene</infon><location offset="722" length="4"/><text>CD80</text></annotation><annotation id="5"><infon key="NCBI Gene identifier">9332</infon><infon key="type">Gene</infon><location offset="753" length="5"/><text>CD163</text></annotation><annotation id="6"><infon key="NCBI Gene identifier">4360</infon><infon key="type">Gene</infon><location offset="759" length="5"/><text>CD206</text></annotation><annotation id="7"><infon key="NCBI Gene identifier">351</infon><infon key="type">Gene</infon><location offset="771" length="6"/><text>Aβ1-42</text></annotation><annotation id="8"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="938" length="16"/><text>apolipoprotein E</text></annotation><annotation id="9"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="956" length="4"/><text>ApoE</text></annotation><annotation id="10"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="972" length="4"/><text>ApoE</text></annotation><annotation id="11"><infon key="NCBI Gene identifier">351</infon><infon key="type">Gene</infon><location offset="1014" length="6"/><text>Aβ1-42</text></annotation><annotation id="12"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1090" length="4"/><text>ApoE</text></annotation><annotation id="13"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1188" length="4"/><text>ApoE</text></annotation><annotation id="14"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1240" length="4"/><text>ApoE</text></annotation><annotation id="15"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1319" length="4"/><text>ApoE</text></annotation><annotation id="16"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1447" length="4"/><text>ApoE</text></annotation><annotation id="17"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1556" length="4"/><text>ApoE</text></annotation><annotation id="18"><infon key="NCBI Gene identifier">351</infon><infon key="type">Gene</infon><location offset="1731" length="6"/><text>Aβ1-42</text></annotation><annotation id="19"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1769" length="4"/><text>ApoE</text></annotation><annotation id="20"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="1902" length="4"/><text>ApoE</text></annotation><annotation id="21"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="2094" length="4"/><text>ApoE</text></annotation><annotation id="22"><infon key="NCBI Gene identifier">348</infon><infon key="type">STARGENE</infon><location offset="2137" length="4"/><text>ApoE</text></annotation></passage></document>
</collection>
